Observational cohort for early spondyloarthritis in Germany

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The German Spondyloarthritis Inception Cohort (GESPIC) is a prospective, longitudinal study initiated in 2000 that focuses on patients with early spondyloarthritis, including ankylosing spondylitis and non-radiographic axial spondyloarthritis. The study aims to track the progression of the disease over time, assess outcomes such as radiographic changes, and identify predictors of these outcomes. Additionally, it evaluates the quality of life and associated costs for patients, expanding to include other related conditions like acute anterior uveitis and Crohn's disease. This multicenter study is conducted across various locations in Germany.

Why it matters

Who can join: the full rules

Main inclusion Criteria:

* Patients with definite diagnosis of axial spondyloarthritis or juvenile spondyloarthritis.
* Patients with definite diagnosis of Crohn's disease.
* Patients with definite diagnosis of acute anterior uveitis.
* Patients with definite diagnosis of psoriatic arthritis with axial involvement.

Where it's running

• Charité - Universitätsmedizin Berlin
  Berlin, Germany Recruiting

Study contacts

• Study coordinator: Denis Poddubnyy, Prof. Dr.
• Email: denis.poddubnyy@charite.de
• Phone: +4930450514582

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Familial IBD Early Risk

  This study tests whether clinical, environmental, and immune factors in first-degree relatives of people with Crohn’s disease or ulcerative colitis can predict who will develop IBD.

  Recruiting Seattle Children's Hospital · Seattle, Washington · NCT07791862

• Biomarker Discovery and Validation Platform for Inflammatory Bowel Disease

  Researchers are testing biomarker models to see if they can measure and predict inflammation and treatment response in people with Crohn's disease, ulcerative colitis, or related IBD.

  Recruiting Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong and 1 other locations · NCT07686406

• Wearable data to spot IBD flareups in people with ulcerative colitis or Crohn's disease

  This study tests whether heart‑rate variability from participants’ own wearables can help predict IBD flares.

  Recruiting at 2 sites Maastricht University Medical Center · 's-Hertogenbosch and 2 other locations · NCT07647640

• Individualizing Anti-TNF Therapy in IBD

  This study tests whether genetic markers can predict which anti-TNF–naïve IBD patients will respond to their first anti-TNF treatment.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07644117

• LRG levels and IBD activity in European patients

  This study will test whether Leucine-rich α2-glycoprotein (LRG) levels reflect disease activity in adults with Crohn’s or ulcerative colitis who are undergoing routine endoscopy in Europe.

  Recruiting Imelda GI Clinical Research Center · Bonheiden · NCT07621783

• CEDUR — German inflammatory bowel disease registry

  This registry collects real-world health and treatment information from adults with Crohn's disease, ulcerative colitis, or indeterminate colitis in Germany to see how care, effectiveness, safety, and costs play out in routine practice.

  Recruiting ImmunoRegister gUG · Hamburg · NCT07319442

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.